Stem cell treatments are being sold abroad for ALS, sports injuries and more. Here’s what the FDA has actually approved.
Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared ...
Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...
Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic disorders. Now, a clinical trial reports that a single dose can ...
Neurons from grafted stem cells contain intrinsic codes for navigating and forming connections, which may improve cell therapy for a brain short-circuited by stroke. Some parts of our bodies bounce ...
Every year, millions of lives are suddenly, swiftly transformed by a stroke, which occurs when a blood vessel traveling towards the brain becomes obstructed, causing neurons to die off. Strokes are ...
Cerebral palsy affects roughly 1 in 345 children in the United States. About 764,000 children and adults live with the condition. Standard treatment focuses on managing symptoms through physical ...
Two early-stage clinical trials demonstrate the safety and potential effectiveness of stem cell therapies to treat Parkinson’s disease (PD), the second most common neurological disease worldwide. PD ...
Stem cell therapy offers a minimally invasive alternative to joint replacement surgery, with recovery times of just one to two weeks compared to months for major surgery Clinical studies show varying ...
A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...
Add Yahoo as a preferred source to see more of our stories on Google. Kim and Khloé Kardashian had stem cell therapy in Mexico overseen by Dr. Adeel Khan. (Photo illustration: Yahoo News; photos: Kim ...
People who received an infusion of stem cells shortly after a heart attack were less likely to develop heart failure than those treated with standard care, according to the largest such trial to date.